InsiderTrades.com logo

NRXP Insider Trading

Insider Ownership Percentage: 19.00%
Insider Buying (Last 12 Months): $46,800.00
Insider Selling (Last 12 Months): $0.00

NRx Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at NRx Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NRx Pharmaceuticals Share Price & Price History

Current Price: $2.01
Price Change: ▼ Price Decrease of -0.06 (-2.90%)
As of 03/25/2025 05:00 PM ET

This chart shows the closing price history over time for NRXP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NRx Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2024Jonathan C JavittChairmanBuy40,000$1.17$46,800.0084,634View SEC Filing Icon  
8/30/2023Aaron GorovitzDirectorBuy3,500$3.20$11,200.0010,500View SEC Filing Icon  
8/22/2023Jonathan C JavittInsiderBuy20,000$3.20$64,000.0034,633View SEC Filing Icon  
12/16/2022Stephen H WillardCEOBuy5,000$11.70$58,500.005,000View SEC Filing Icon  
12/16/2022Voorhees Seth VanCFOBuy3,000$11.00$33,000.004,633View SEC Filing Icon  
12/7/2022Jonathan C JavittDirectorSell40,000$10.00$400,000.001,289,999View SEC Filing Icon  
11/29/2022Daniel C JavittMajor ShareholderSell1,373$15.00$20,595.00964,323View SEC Filing Icon  
11/28/2022Patrick John FlynnDirectorBuy175$12.50$2,187.50175View SEC Filing Icon  
11/25/2022Voorhees Seth VanCFOBuy1,633$11.10$18,126.301,637View SEC Filing Icon  
11/18/2022Chaim HurvitzDirectorBuy4,040$11.00$44,440.0050,000View SEC Filing Icon  
11/17/2022Daniel C JavittMajor ShareholderSell3,301$10.50$34,660.50965,696View SEC Filing Icon  
11/16/2022Chaim HurvitzDirectorBuy28,781$9.90$284,931.9028,781View SEC Filing Icon  
11/11/2022Daniel C JavittMajor ShareholderSell4,920$10.10$49,692.00982,370View SEC Filing Icon  
7/29/2022Daniel C JavittMajor ShareholderSell7,840$101.00$791,840.0098,729View SEC Filing Icon  
6/6/2022Daniel C JavittMajor ShareholderSell1,156$67.00$77,452.00127,434View SEC Filing Icon  
6/3/2022Daniel C JavittMajor ShareholderSell2,435$70.00$170,450.00128,590View SEC Filing Icon  
6/1/2022Jonathan C JavittInsiderBuy1,000$5,800.00$5,800,000.001,463View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NRx Pharmaceuticals (NASDAQ:NRXP)

4.27% of NRx Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NRXP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NRx Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Squarepoint Ops LLC25,299$56K0.0%N/A0.161%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC27,624$61K0.0%N/A0.176%Search for SEC Filing on Google Icon
2/17/2025Anson Funds Management LP185,660$0.41M0.0%+30.3%1.183%Search for SEC Filing on Google Icon
2/14/2025AdvisorShares Investments LLC310,314$0.68M0.1%+138.5%1.977%Search for SEC Filing on Google Icon
2/14/2025Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096%Search for SEC Filing on Google Icon
11/15/2024Anson Funds Management LP142,525$0.24M0.0%N/A1.326%Search for SEC Filing on Google Icon
11/13/2024Townsquare Capital LLC15,041$25K0.0%N/A0.140%Search for SEC Filing on Google Icon
8/8/2024AdvisorShares Investments LLC108,085$0.28M0.0%-82.4%1.010%Search for SEC Filing on Google Icon
8/6/2024One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141%Search for SEC Filing on Google Icon
2/14/2024AdvisorShares Investments LLC642,632$0.30M0.1%N/A0.755%Search for SEC Filing on Google Icon
1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165%Search for SEC Filing on Google Icon
11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065%Search for SEC Filing on Google Icon
2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086%Search for SEC Filing on Google Icon
1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044%Search for SEC Filing on Google Icon
1/27/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%Search for SEC Filing on Google Icon
1/18/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%Search for SEC Filing on Google Icon
11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094%Search for SEC Filing on Google Icon
5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023%Search for SEC Filing on Google Icon
4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027%Search for SEC Filing on Google Icon
2/9/2022Wolverine Asset Management LLC37,105$0.18M0.0%-12.8%0.063%Search for SEC Filing on Google Icon
2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020%Search for SEC Filing on Google Icon
11/15/2021Penserra Capital Management LLC2,956$27K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/12/2021Wolverine Asset Management LLC42,568$0.39M0.0%+118.4%0.079%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.42,885$0.40M0.0%+1,197.6%0.080%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285%Search for SEC Filing on Google Icon
8/16/2021Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626%Search for SEC Filing on Google Icon
8/16/2021Ionic Capital Management LLC35,721$0.42M0.0%N/A0.075%Search for SEC Filing on Google Icon
8/16/2021Linden Advisors LP364,352$4.23M0.0%N/A0.760%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp130,633$1.52M0.0%N/A0.273%Search for SEC Filing on Google Icon
8/13/2021Yakira Capital Management Inc.11,923$0.14M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC34,475$0.40M0.0%N/A0.072%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.637,416$7.41M0.0%N/A1.330%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NRx Pharmaceuticals logo
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.
Read More on NRx Pharmaceuticals

Today's Range

Now: $2.01
Low: $1.99
High: $2.07

50 Day Range

MA: $2.70
Low: $2.01
High: $4.49

52 Week Range

Now: $2.01
Low: $1.10
High: $6.01

Volume

155,571 shs

Average Volume

453,654 shs

Market Capitalization

$34.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of NRx Pharmaceuticals?

NRx Pharmaceuticals' top insider investors include:
  1. Jonathan C Javitt (Chairman)
  2. Jonathan C Javitt (Insider)
  3. Aaron Gorovitz (Director)
Learn More about top insider investors at NRx Pharmaceuticals.

Who are the major institutional investors of NRx Pharmaceuticals?

NRx Pharmaceuticals' top institutional investors include:
  1. AdvisorShares Investments LLC — 1.98%
  2. Anson Funds Management LP — 1.18%
  3. Millennium Management LLC — 0.18%
  4. Squarepoint Ops LLC — 0.16%
  5. Sassicaia Capital Advisers LLC — 0.10%
  6. Citadel Advisors LLC — 0.00%
Learn More about top institutional investors of NRx Pharmaceuticals stock.

Which institutional investors are buying NRx Pharmaceuticals stock?

During the previous quarter, NRXP stock was acquired by institutional investors including:
  1. AdvisorShares Investments LLC
  2. Anson Funds Management LP
  3. Millennium Management LLC
  4. Squarepoint Ops LLC
  5. Sassicaia Capital Advisers LLC
  6. Citadel Advisors LLC
In the previous year, these company insiders have bought NRx Pharmaceuticals stock:
  1. Jonathan C Javitt (Chairman)
  2. Jonathan C Javitt (Insider)
  3. Aaron Gorovitz (Director)
Learn More investors buying NRx Pharmaceuticals stock.